Efficacy of longevity interventions in C. elegans is determined by early life activity of RNA splicing factors.

eCOMPASS guides drug developers to the optimal candidate with its lap-in-the-loop platform.

Successful lab-in-the-loop approaches optimize RNA therapeutic design to be easily manufactured and produced.

The mRNA Innovators Award offers matching funds to design and validate a therapeutic of interest using Eclipsebio's design models and characterization methods.

Discover how closed-loop RNA development pairs design and sequencing to accelerate better therapeutics.